The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
What Is A Biventricular Pacemaker Or A CRT Device, How Is It Implanted, And Who Is A Good Candidate?
Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing (LBBAP) high-voltage device. These next ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An implantable device that shocks an erratically beating heart back into ...
The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
WASHINGTON, DC—The vast majority of patients who develop an infection related to a cardiac implanted electronic device (CIED) do not have the hardware extracted in a timely manner, and these patients ...
St. Anthony Regional Hospital has expanded its advanced cardiac care offerings with the successful implantation of the world’s smallest transvenous defibrillation lead. The procedure was performed by ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results